Development of biomarkers in multiple sclerosis.

Abstract excerpt

Multiple sclerosis is a complex disease, as several pathophysiological processes (including inflammation, demyelination, axonal damage and repair mechanisms) participate in the disease process. Furthermore, as new pathological evidence reveals, these processes are not uniformly represented across patient populations but can selectively predominate in individual patients, thus contributing to the heterogeneity in...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Biomarkers
• Share to Decision Making
• Share to Information Storage and Retrieval